These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1962681)

  • 1. New drugs. The class of 1991.
    Meyer C
    Am J Nurs; 1991 Dec; 91(12):40-3. PubMed ID: 1962681
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs of 1991.
    Hussar DA
    Am Pharm; 1992 Apr; NS32(4):37-69. PubMed ID: 1566737
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs and product approvals from 2001.
    Taylor SE
    Tex Dent J; 2002 Dec; 119(12):1186-98. PubMed ID: 12592740
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic implications of the drug lag.
    Wardell WM
    Clin Pharmacol Ther; 1974 Jan; 15(1):73-96. PubMed ID: 4150345
    [No Abstract]   [Full Text] [Related]  

  • 5. Fast track for AIDS and cancer drugs.
    Gershon D
    Nature; 1990 Aug; 346(6286):685. PubMed ID: 2388690
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA launches "new use initiative".
    Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604
    [No Abstract]   [Full Text] [Related]  

  • 7. The year's new drugs.
    Rodman MJ
    RN; 1979 Jan; 42(1):33-46. PubMed ID: 252135
    [No Abstract]   [Full Text] [Related]  

  • 8. New drugs 2002. Part II.
    Hussar DA
    Nursing; 2002 Apr; 32(4):56-62; quiz 62-3. PubMed ID: 11969021
    [No Abstract]   [Full Text] [Related]  

  • 9. New therapeutic agents marketed in 1995.
    Hussar DA
    Pa Med; 1996 Jun; 99(6):35-6, 39-40. PubMed ID: 8710394
    [No Abstract]   [Full Text] [Related]  

  • 10. 27th Annual JPMorgan Healthcare Conference--Gilead and Endo Pharmaceuticals.
    Gale S; Mason VL
    IDrugs; 2009 Mar; 12(3):145-8. PubMed ID: 19333890
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs of 1997.
    Hussar DA
    J Am Pharm Assoc (Wash); 1998; 38(2):155-95; quiz 195-8. PubMed ID: 9654847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoscience moves from the laboratory to the clinic.
    Rowe PM
    Lancet; 1999 Jul; 354(9176):402. PubMed ID: 10437881
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insights and therapeutic guidelines on the use of drugs in kidney insufficiency].
    De Broe ME
    Acta Clin Belg; 1974; 29(4):191-211. PubMed ID: 4154694
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs from 1991-1992.
    Gage TW
    Tex Dent J; 1993 Jul; 110(7):19-25. PubMed ID: 8273018
    [No Abstract]   [Full Text] [Related]  

  • 15. Class effects and labeling of antihypertensive drugs.
    Pickering TG
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):215-20. PubMed ID: 16523001
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on drugs in renal failure.
    Bennett WM
    Adv Nephrol Necker Hosp; 1986; 15():379-94. PubMed ID: 3082117
    [No Abstract]   [Full Text] [Related]  

  • 17. New discoveries still abundant in monoclonal antibody research.
    Garber K
    J Natl Cancer Inst; 2000 Sep; 92(18):1462-4. PubMed ID: 10995796
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA new drug approvals in 2010.
    Wynn RL
    Gen Dent; 2011; 59(4):250-3. PubMed ID: 21903562
    [No Abstract]   [Full Text] [Related]  

  • 19. Some problems with antihypertensive drug studies in the context of the new guidelines.
    Rose M; McMahon FG
    Am J Hypertens; 1990 Feb; 3(2):151-5. PubMed ID: 2407266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
    Lipicky R
    J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.